|1.||Adachi, Jonathan D: 1 article (01/2015)|
|2.||Kennedy, Courtney: 1 article (01/2015)|
|3.||Papaioannou, Alexandra: 1 article (01/2015)|
|4.||Thabane, Lehana: 1 article (01/2015)|
|5.||Li, Guowei: 1 article (01/2015)|
|6.||Ioannidis, George: 1 article (01/2015)|
|7.||Kang, Minho: 1 article (01/2013)|
|8.||Gade, Aravind R: 1 article (01/2013)|
|9.||Akbarali, Hamid I: 1 article (01/2013)|
|10.||Mishra, Kusum L: 1 article (01/2009)|
03/01/1980 - "To determine the clinical and functional characteristics of isolated platelet factor 3 (PF-3) deficiency, platelet function studies were carried out in 316 patients who were suspected of having a bleeding tendency. "
01/01/2009 - "Platelet Factor 3 dysfunction was diagnosed to be the cause of bleeding. "
03/01/1980 - "Bleeding disorder due to an isolated platelet factor 3 deficiency."
04/30/1975 - "A constitutional platelet function disorder in a twelve year-old girl characterized by a lifelong bleeding tendency, prolonged bleeding time, normal platelet count, normal clot retraction, normal platelet factor 3 activity and impaired platelet aggregation was reported. "
11/01/2005 - "These patients developed painful knee swelling, persistent bleeding and/or wound breakdown, a platelet factor 3 availability defect being identified in all cases. "
01/01/1999 - "It produced a significant reduction in platelet aggregation and platelet factor-3 (PF(3)) availability ( P < 0.001) without being associated with thrombocytopenia. "
07/01/1973 - "[Measurement of platelet factor 3 during central thrombocytopenia]."
10/01/1979 - "[Blood serum antiplatelet activity in acute leukemia and idiopathic thrombopenia studied with the aid of the platelet factor 3 availability test]."
07/01/1965 - "CHANGE IN PLATELET FACTOR 3 AS A MEANS OF DEMONSTRATING IMMUNE REACTIONS INVOLVING PLATELETS: ITS USE AS A TEST FOR QUINIDINE-INDUCED THROMBOCYTOPENIA."
08/01/1990 - "Bacterial endotoxin binds to platelets and causes platelet aggregation, thrombocytopenia, increase in thromboxane A2 production, serotonin release and increase in the generation of platelet factor 3 procoagulant activity. "
01/15/1985 - "Findings not previously reported included diffuse, pulmonary interstitial radiopacities; weak-positive results for blastomycosis, using agar gel immunodiffusion; normal platelet counts; hemorrhage despite platelet counts greater than 100,000/mm3, and positive results for platelet factor 3 and antinuclear antibody assays. "
12/15/1995 - "Platelet factor 3 (PF3) was assayed by Russell's viper venom (RVV) in three plasma fractions, platelet-rich plasma (PRP), platelet poor plasma (PPP), and 0.1 microns particle-filtered plasma (PFP), in 42 healthy controls, 34 patients with recent cerebrovascular accidents (CVA) and 28 with recent ischemic events from coronary artery disease (CAD). "
02/28/1978 - "Studies of 11 patients with haemorrhagic stroke revealed no significant change in kaolin cephalin clotting time, prothrombin time, thrombin time, PF 3 availability, platelet count and factor V and VIII during the first week. "
|4.||Factor V (Coagulation Factor V)
|5.||Adenosine Diphosphate (ADP)
|9.||Thromboxane A2 (A2, Thromboxane)
|1.||Angioplasty (Angioplasty, Transluminal)